CoChat

Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease

Open access
Marrie, R. A., Walld, R., Bolton, J. M., Sareen, J., Walker, J. R., Patten, S. B., Singer, A., Lix, L. M., Hitchon, C. A., El-Gabalawy, R., Katz, A., Fisk, J. D., Bernstein, C. N., for the CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease · 2019 · Epidemiology and Psychiatric Sciences

The DOI matches its Crossref record, with a small difference in title or year; 41 of the 41 references it cites were found in a registry or an index; none of the 19 sources its claims cite is checked for support yet.

Abstract

AIMS: After the diagnosis of immune-mediated inflammatory diseases (IMID) such as inflammatory bowel disease (IBD), multiple sclerosis (MS) and rheumatoid arthritis (RA), the incidence of psychiatric comorbidity is increased relative to the general population. We aimed to determine whether the incidence of psychiatric disorders is increased in the 5 years before the diagnosis of IMID as compared with the general population. METHODS: Using population-based administrative health data from the Canadian province of Manitoba, we identified all persons with incident IBD, MS and RA between 1989 and 2012, and cohorts from the general population matched 5 : 1 on year of birth, sex and region to each disease cohort. We identified members of these groups with at least 5 years of residency before and after the IMID diagnosis date. We applied validated algorithms for depression, anxiety disorders, bipolar disorder, schizophrenia, and any psychiatric disorder to determine the annual incidence of these conditions in the 5-year periods before and after the diagnosis year. RESULTS: We identified 12 141 incident cases of IMID (3766 IBD, 2190 MS, 6350 RA) and 65 424 matched individuals. As early as 5 years before diagnosis, the incidence of depression [incidence rate ratio (IRR) 1.54; 95% CI 1.30-1.84) and anxiety disorders (IRR 1.30; 95% CI 1.12-1.51) were elevated in the IMID cohort as compared with the matched cohort. Similar results were obtained for each of the IBD, MS and RA cohorts. The incidence of bipolar disorder was elevated beginning 3 years before IMID diagnosis (IRR 1.63; 95% CI 1.10-2.40). CONCLUSION: The incidence of psychiatric comorbidity is elevated in the IMID population as compared with a matched population as early as 5 years before diagnosis. Future studies should elucidate whether this reflects shared risk factors for psychiatric disorders and IMID, a shared final common inflammatory pathway or other aetiology.

Overview

CoChat Summary

TL;DR

In a Manitoba population-based retrospective cohort study, psychiatric disorder incidence was higher in people who later developed IBD, MS, or RA than in matched general-population controls, beginning as early as 5 years before IMID diagnosis. The pre-diagnosis signal was clearest for depression and anxiety, with bipolar disorder elevated starting 3 years before diagnosis.

Key findings

  • The study identified 12,141 incident IMID cases (3,766 IBD; 2,190 MS; 6,350 RA) and 65,424 matched individuals.
  • In the combined IMID cohort, the age- and sex-standardized incidence of any psychiatric disorder was higher than in matched controls as early as 5 years before diagnosis (IRR 1.60; 95% CI 1.36–1.89), and was highest in the diagnosis year.
  • Also in the combined IMID cohort, depression was elevated 5 years before diagnosis (IRR 1.54; 95% CI 1.30–1.84) and anxiety disorders were elevated 5 years before diagnosis (IRR 1.30; 95% CI 1.12–1.51).
  • Bipolar disorder was elevated beginning 3 years before IMID diagnosis (IRR 1.63; 95% CI 1.10–2.40); findings were generally similar across the IBD, MS, and RA subcohorts, while schizophrenia could not be modeled because of small cell sizes.

Methods

  • Retrospective, population-based cohort study using linked administrative health data from Manitoba, Canada.
  • Included incident IBD, MS, and RA cases from 1989–2012 (with validated case definitions) and 5:1 matched general-population controls matched on year of birth, sex, and region; analyses were limited to those with at least 5 years of residency before and after the IMID diagnosis date.
  • Estimated annual incidence of depression, anxiety disorder, bipolar disorder, schizophrenia, and any psychiatric disorder in the 5-year pre-diagnosis, diagnosis-year, and 5-year post-diagnosis periods, using age- and sex-standardized incidence rates, incidence rate ratios, and multivariable negative binomial regression adjusted for pre-specified covariates.

Limitations

  • The paper states the study was limited to a single Canadian province, which may reduce generalisability.
  • The authors note administrative data capture only health-system contacts and therefore miss psychiatric disorders diagnosed by non-physician mental health providers or untreated cases; this limitation applies to both IMID and non-IMID groups.
  • The paper states that administrative data lacked clinical detail, so the study could not assess associations with IMID severity or determine whether pre-diagnosis psychiatric disorders were prodromal IMID symptoms, shared comorbidity, or a causal risk factor.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1017/s2045796017000579

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. Age- and sex-standardised incidence rates of psychiatric disorders in the immune-mediated inflammatory disease (IMID) and matched cohorts 5 years before and 5 years after IMID diagnosis.
Fig. 1. Age- and sex-standardised incidence rates of psychiatric disorders in the immune-mediated inflammatory disease (IMID) and matched cohorts 5 years before and 5 years after IMID diagnosis.CC BY · PubMed Central
Fig. 2. Age- and sex-standardised incidence rate ratios for psychiatric disorders in the immune-mediated inflammatory disease (IMID) and matched cohorts 5 years before and 5 years after IMID diagnosis.
Fig. 2. Age- and sex-standardised incidence rate ratios for psychiatric disorders in the immune-mediated inflammatory disease (IMID) and matched cohorts 5 years before and 5 years after IMID diagnosis.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 10 Not checked · 34 Own results and interpretations

14 more claims

Create a free account to see all 44 claims and to verify the 19 references still open.

See all claims — free account
  • It may state two separate claims as one. 16
  • Probably not a substantial claim. 11

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 9

  1. 2004, The Journal of Rheumatology, 31, 58
  2. 2007, The Burden of Neurological Diseases, Disorders and Injuries in Canada
  3. 2013, Journal of Neuroinflammation, 10, 43
  4. 2005, Journal of Rheumatology, 32, 1013
  5. 2014, ACR/ARHP Annual Meeting
  6. 2003, Arthritis in Canada: An Ongoing Challenge
  7. 2012, Gastroenterology & Hepatology (New York), 8, 173
  8. 2012, Guidelines for ATC Classification and DDD Assignment 2013
  9. 2016, International Psychogeriatrics, 1

Cited by

See all 145

Metadata

Authors
Marrie, R. A., Walld, R., Bolton, J. M., Sareen, J., Walker, J. R., Patten, S. B., Singer, A., Lix, L. M., Hitchon, C. A., El-Gabalawy, R., Katz, A., Fisk, J. D., Bernstein, C. N., & for the CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease
Affiliations
  • University of Manitoba (CA)
  • University of Calgary (CA)
  • Dalhousie University (CA)
Corresponding author
Marrie, R. A.
Venue
Epidemiology and Psychiatric Sciences
Published
2017-11-03
Volume
28
Issue
03
Pages
333-342
ISSN
  • 2045-7960 (ISSN-L)
  • 2045-7979
OpenAlex
W2765581691
Cited by
144
References
41
Citations by year
2026: 9 · 2025: 15 · 2024: 23 · 2023: 16 · 2022: 18 · 2021: 18 · 2020: 25 · 2019: 11 · 2018: 7
FWCI
3.92
Type
journal article
Language
en
Open access
Locations
  • Epidemiology and Psychiatric Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Research Manitoba
  • Crohn's and Colitis Canada
  • Canadian Institutes of Health Research (135234_1, 333252)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords
immune-mediated inflammatory diseases, psychiatric comorbidity, depression, anxiety disorders, bipolar disorder, schizophrenia, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis
MeSH terms
Adult, Arthritis, Rheumatoid, Mental Disorders, Female, Humans, Male, Manitoba, Middle Aged, Multiple Sclerosis, Risk Factors, Inflammatory Bowel Diseases, Comorbidity, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease. https://app.cochat.ai/papers/10.1017/s2045796017000579
The paper
Marrie, R. A., Walld, R., Bolton, J. M., Sareen, J., Walker, J. R., Patten, S. B., Singer, A., Lix, L. M., Hitchon, C. A., El-Gabalawy, R., Katz, A., Fisk, J. D., Bernstein, C. N., & for the CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease. (2019). Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease. Epidemiology and Psychiatric Sciences. https://doi.org/10.1017/s2045796017000579

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.